AFAR Association Française des Affaires Réglementaires

What AFAR Association Française des Affaires Réglementaires does

AFAR (Association Française des Affaires Règlementaires) is a French nonprofit professional association headquartered in Paris that serves regulatory affairs professionals working in the pharmaceutical and health products sector. The association operates a membership-based platform delivering four core offerings: La Gazette, a monthly publication curated by an editorial committee and distributed to members; thematic working groups covering specific regulatory domains (LEA, Communication, Exploitant, Pub); in-person thematic evenings hosted primarily at Metafore Boetie-Saint-Augustin in Paris 8ème, frequently co-organized with academic and regulatory partners; and a job and internship board connecting members with pharmaceutical employers.

The organization maintains formal collaborations with France's official professional orders — the Conseil National de l'Ordre des Médecins (CNOM) and the Conseil National de l'Ordre des Pharmaciens (CNOP) — as well as with academic institutions such as Université de Lille's Master 2 AREIPS program. These partnerships enable AFAR to convene members around high-relevance regulatory developments, including the five-year retrospective on the Loi Encadrement des Avantages (LEA) held on April 9, 2026.

AFAR is governed by a member-elected board of directors (four members were re-elected at the General Assembly on March 31, 2026) and operates without a disclosed parent, external investor, or capital structure. Revenue mechanics are not publicly disclosed but are inferred to derive primarily from individual membership dues, supplemented by job board postings, event sponsorships, and advertising placements in La Gazette. No proprietary technology, AI capabilities, or app-based distribution channels are present; the association runs on a standard website (afar.asso.fr) and in-person programming.

Name

AFAR Association Française des Affaires Réglementaires

Legal name

ASSOCIATION FRANÇAISE DES AFFAIRES RÉGLEMENTAIRES

Website

https://afar.asso.fr

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

AFAR is a Paris-based French nonprofit professional association serving pharmaceutical regulatory affairs professionals through membership, a monthly publication (La Gazette), specialized working groups, in-person thematic events, and a job board.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

AFAR is a French professional association that supports regulatory affairs professionals working in the pharmaceutical, biotech, medical device, and cosmetics industries. It offers member services including a publication (La Gazette), working groups (groupes de travail), thematic evenings, a job board, and educational partnerships with French universities and professional bodies.

Product overview

AFAR is a French professional association for regulatory affairs in the healthcare/pharmaceutical industry. The organization offers a membership-based platform providing access to publications (La Gazette), thematic working groups, professional events, and a job board. The core offering is professional networking and knowledge sharing among regulatory affairs specialists rather than a software product.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Dossiers received in Authorization: 16,898 (2024) → 19,219 (2025) (+13.7%)
• +1 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Université de Lille - Master 2 AREIPScoreStrategic or Co-development PartnerAFAR partners with the Master 2 Affairs Réglementaires Européennes et Internationales des Produits de Santé (AREIPS) of Université de Lille for thematic evenings, providing academic collaboration and professional education in regulatory affairs.
• CNOM (Conseil National de l'Ordre des Médecins)coreStrategic or Co-development PartnerCollaboration on the Loi Encadrement des Avantages (LEA) thematic evenings. CNOM shared activity data including 19,219 authorization dossiers and 69,417 recommendation dossiers in 2025, along with best practices for dossier processing.
• CNOP (Conseil National de l'Ordre des Pharmaciens)coreStrategic or Co-development PartnerCollaboration on LEA law thematic evenings. CNOP shared insights on declaration volumes, refusal reasons, and ongoing work on treatment doctrine and specific cases (market research notices, simplified conventions).
• GT LEA de l'AFARminorOthersInternal working group dedicated to the Encadrement des Avantages (LEA) law, organizing thematic evenings and providing expertise on the regulatory framework.

Scale indicators1 record

Recent moves5 records

Expansion highlights3 records

Direct peers

• RAPS (Regulatory Affairs Professionals Society): Global professional society serving regulatory affairs professionals across healthcare products, offering certifications, publications, and educational events. Closest global analog to AFAR with broader geographic reach but similar core mission of advancing the regulatory profession.
• TOPRA (The Organisation for Professionals in Regulatory Affairs): UK-based professional membership association dedicated to regulatory affairs in pharmaceuticals, medical devices, and biotech. Most directly comparable to AFAR in mission (regulatory affairs professional community), membership model, and education/events offerings, differing primarily by geographic focus.

Regional players

• LEEM (Les Entreprises du Médicament): French professional association representing pharmaceutical companies operating in France. Serves the same French pharmaceutical ecosystem as AFAR but from an industry/employer perspective rather than the regulatory affairs professional community.
• Pharma.be: Belgian pharmaceutical industry association that also addresses regulatory affairs topics at EU level. Provides a regional parallel to AFAR's model of national industry-focused regulatory community.

Broad incumbents

• ISPE (International Society for Pharmaceutical Engineering): Global association for pharmaceutical engineering and manufacturing professionals. Adjacent to AFAR in serving pharmaceutical industry professionals with technical training, publications, and community offerings, though focused on manufacturing rather than regulatory affairs.
• EUCOPE (European Confederation of Pharmaceutical Entrepreneurs): European trade association representing small-to-mid pharmaceutical and biotech companies on regulatory and policy issues. Comparable as a pharma regulatory/policy community serving European industry stakeholders.
• DIA (Drug Information Association): Global association serving the entire life sciences R&D value chain including regulatory, clinical, and pharmacovigilance functions. Overlaps with AFAR on regulatory affairs content and serves similar pharmaceutical industry professionals at larger scale.
• IFPMA (International Federation of Pharmaceutical Manufacturers and Associations): Global industry association representing pharmaceutical companies and associations, including on regulatory policy matters. Touches AFAR's regulatory affairs community through policy advocacy at international level.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/afarassociation

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AFAR Association Française des Affaires Réglementaires